Call Boomerang Books 1300 36 33 32

Description - Drug-induced Mitochondrial Dysfunction by James A. Dykens

This is the definitive, one-stop resource on preclinical drug evaluation for potential mitochondrial toxicity, addressing the issue upfront in the drug development process. It discusses mitochondrial impairment to organs, skeletal muscle, and nervous systems and details methodologies used to assess mitochondria function. It covers both in vitro and in vivo methods for analysis and includes the latest models. This is the authoritative reference on drug-induced mitochondrial dysfunction for safety assessment professionals in the pharmaceutical industry and for pharmacologists and toxicologists in both drug and environmental health sciences.

Buy Drug-induced Mitochondrial Dysfunction by James A. Dykens from Australia's Online Independent Bookstore, Boomerang Books.

Book Details

ISBN: 9780470111314
ISBN-10: 0470111313
Format: Hardback
(237mm x 165mm x 33mm)
Pages: 616
Imprint: Wiley-Blackwell
Publisher: John Wiley and Sons Ltd
Publish Date: 1-Sep-2008
Country of Publication: United States

Book Reviews - Drug-induced Mitochondrial Dysfunction by James A. Dykens

» Have you read this book? We'd like to know what you think about it - write a review about Drug-induced Mitochondrial Dysfunction book by James A. Dykens and you'll earn 50c in Boomerang Bucks loyalty dollars (you must be a Boomerang Books Account Holder - it's free to sign up and there are great benefits!)

Write Review

Author Biography - James A. Dykens

James A. Dykens, PhD , is an Associate Research Fellow in Pfizer's Drug Safety Research and Development Department. Currently in Sandwich, England, he previously worked in a similar role with Pfizer in La Jolla, California. Prior to his work with Pfizer, Dr. Dykens was the senior director of technology development for MIGENIX Inc., a senior scientist and the director of business development at MitoKor, Inc., and a senior principal scientist at Parke-Davis Pharmaceutical Research. Dr. Dykens has published extensively on drug-induced mitochondrial dysfunction, on the role of mitochondrial free radical production in the etiology of neurodegenerative diseases, and on the physiological ecology of marine symbioses. Yvonne Will, PhD , works in Pfizer's Exploratory Safety Differentiation Group in Groton, Connecticut. Prior to this position, she led Pfizer's Investigative Biochemical Toxicity Group within the Drug Safety Research and Development Department in La Jolla. Before joining Pfizer, Dr. Will worked on mitochondrial proteomics and physiology at MitoKor, Inc. Dr. Will has authored a host of articles and book chapters. She is a member of the Society of Toxicology and a frequent speaker for groups like ACT and World Pharmaceutical Congress.